SGYP Profile — Synergy Pharmaceuticals Inc
Synergy Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of gastrointestinal therapies. Co.'s commercial product, plecanatide, is approved in the U.S. under the trademark name TRULANCE, for the treatment of adults with chronic idiopathic constipation. In addition, Co. is developing TRULANCE for the treatment of adults with irritable bowel syndrome with constipation. Co. is also exploring opioid-induced constipation as a potential lifecycle growth opportunity for TRULANCE. Dolcanatide, Co.'s second product candidate, is being evaluated for inflammatory bowel disease.